Healthcare in India: Strategic Perspectives

Go to class
Write Review

Free Online Course: Healthcare in India: Strategic Perspectives provided by edX is a comprehensive online course, which lasts for 5 weeks long, 3-4 hours a week. The course is taught in English and is free of charge. Healthcare in India: Strategic Perspectives is taught by Chirantan Chatterjee.

Overview
  • The Indian healthcare sector is garnering global attention. Be it the evolution of Indian pharmaceutical firms, low-cost hospitals or disruptive start-ups, the sector is a laboratory of myriad market forces impacting innovation, choices and societal welfare. At the same time, India continues to battle with an inadequate healthcare infrastructure and a rising disease burden.

    This business course applies a strategic lens to the sector’s submarkets including hospitals, pharmaceutical firms and diagnostic equipment providers. You will examine the role of disruptive innovation and the ways in which public policy shapes the evolution of healthcare markets. With this framework, you will be able to evaluate which employer to join, which healthcare stocks to invest in, where the exciting business opportunities lie, and what are the unmet needs in this sector that can be addressed by a startup.

    If you are a healthcare enthusiast, a part of the industry, a policy maker, an investor or an entrepreneur, this is the course for you.

Syllabus
  • Week 1: Strategy Foundations 101
    Introduction to basic strategy concepts, including Porter’s five forces, resource-based view, institution-based view and related notions

    Week 2: The Indian Hospital Sector
    Strategic overview of a specific sub-market in Indian healthcare

    Week 3: The Indian Pharmaceutical Sector
    Discussion of current and key trends in the sub-market

    Week 4: The Indian Medical Devices and Diagnostics Sector
    Case study discussion

    Week 5: Disruptive Innovation and Regulation in Indian Healthcare
    Interview with industry leader(s) across the Indian hospital, pharmaceutical and medical devices and diagnostics sectors